NASDAQ:KIDS OrthoPediatrics Q3 2024 Earnings Results & Report $31.65 +0.24 (+0.76%) Closing price 04:00 PM EasternExtended Trading$31.69 +0.04 (+0.13%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. OrthoPediatrics reported Q3 2024 earnings on January 14, 2025. The company reported EPS of -$0.18, while revenue was $54.57 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2024Report DateJanuary 14, 2025TimeAfter Market Closes OrthoPediatrics EPS ResultsActual EPS-$0.18Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate6 of last 8 quartersOrthoPediatrics Revenue ResultsActual Revenue$54.57 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile OrthoPediatrics Q3 2024 Earnings FAQ Did OrthoPediatrics beat earnings estimates for Q3 2024? OrthoPediatrics (NASDAQ:KIDS) reported earnings of -$0.18 per share for Q3 2024. The report was announced on Tuesday, January 14, 2025. What was OrthoPediatrics' revenue for Q3 2024? OrthoPediatrics reported revenue of $54.57 million for Q3 2024. OrthoPediatrics Earnings HeadlinesOrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance SystemNovember 9, 2026 | globenewswire.comOrthoPediatrics to Participate in Upcoming ConferencesNovember 2, 2026 | globenewswire.comYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strategy guide, titled How To Turn $100 Options Into $1,000 Gains, before it moves behind a paywall. The guide walks through options trading concepts the team uses in its own research and education materials. Once the paywall goes up, free access ends for good.November 18 at 1:00 AM | TradeWins (Ad)OrthoPediatrics consensus price target rises 15.73% to $31.36November 2, 2026 | msn.comOrthoPediatrics (KIDS) Stock Sees Fair Value Lift After Higher Growth And New Product WinsOctober 30, 2026 | finance.yahoo.comOrthoPediatrics Corp (KIDS) (Q3 2026) Earnings Call Highlights: Record Revenue and Raised GuidanceOctober 28, 2026 | finance.yahoo.comSee More OrthoPediatrics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like OrthoPediatrics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OrthoPediatrics and other key companies, straight to your email. Email Address About OrthoPediatricsOrthoPediatrics (NASDAQ:KIDS) develops and markets orthopedic implants and instruments designed specifically for children and adolescents. Its products support surgeons treating a range of pediatric conditions, including fractures, spinal deformities, limb-length differences and other orthopedic disorders. The company’s portfolio includes systems for trauma and deformity correction, scoliosis treatment, limb lengthening and external fixation, as well as specialized surgical instruments. It also provides related education and support for pediatric orthopedic surgeons and care teams. Founded in 2006 and headquartered in Warsaw, Indiana, OrthoPediatrics serves hospitals and surgeons in the United States and internationally through its sales network and distribution partners. The company focuses on addressing the distinct needs of growing children, whose bones and anatomy can require different treatment approaches from those used for adults.View OrthoPediatrics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes ShapeGeneral Motors Faces a Cost Squeeze as Factory Automation Takes Center StageNVIDIA's Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?5 Consumer Discretionary Plays Showing Strength During the Tech Sell-OffAMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?Viking’s Low-Water Miss Looks Like a Buy-the-Dip OpportunityDisney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout Upcoming Earnings NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026)Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.